Canada Life
CSTL icon

Canada Life’s Castle Biosciences CSTL Stock Holding History

Canada Life’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80K Hold
3,244
– – ﹤0.01% 1712
2025
Q4 		$126K Sell
3,244
-7,469
-70% -$241K ﹤0.01% 1692
2025
Q3 		$239K Hold
10,713
– – ﹤0.01% 1679
2025
Q2 		$219K Hold
10,713
– – ﹤0.01% 1698
2025
Q1 		$215K Hold
10,713
– – ﹤0.01% 1716
2024
Q4 		$285K Sell
10,713
-2,506
-19% -$76.3K ﹤0.01% 1712
2024
Q3 		$378K Hold
13,219
– – ﹤0.01% 1726
2024
Q2 		$287K Sell
13,219
-3,673
-22% -$81.8K ﹤0.01% 1778
2024
Q1 		$374K Hold
16,892
– – ﹤0.01% 1743
2023
Q4 		$362K Buy
16,892
+5,659
+50% +$99.6K ﹤0.01% 1765
2023
Q3 		$189K Hold
11,233
– – ﹤0.01% 1869
2023
Q2 		$155K Buy
11,233
+2,829
+34% +$57.3K ﹤0.01% 1858
2023
Q1 		$191K Hold
8,404
– – ﹤0.01% 1873
2022
Q4 		$199K Buy
8,404
+3,060
+57% +$70.9K ﹤0.01% 1888
2022
Q3 		$139K Buy
5,344
+4,373
+450% +$123K ﹤0.01% 1936
2022
Q2 		$21K Hold
971
– – ﹤0.01% 2251
2022
Q1 		$46K Hold
971
– – ﹤0.01% 2171
2021
Q4 		$41K Hold
971
– – ﹤0.01% 2221
2021
Q3 		$65K Sell
971
-321
-25% -$22.6K ﹤0.01% 2164
2021
Q2 		$94K Hold
1,292
– – ﹤0.01% 2101
2021
Q1 		$88K Buy
1,292
+342
+36% +$25.7K ﹤0.01% 2134
2020
Q4 		$64K Hold
950
– – ﹤0.01% 2208
2020
Q3 		$49K Hold
950
– – ﹤0.01% 2182
2020
Q2 		$36K Buy
+950
New +$32.5K ﹤0.01% 2338

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Life's CSTL Position: Q1 2026 in Review

Canada Life held its Castle Biosciences (CSTL) position steady in Q1 2026 at 3,244 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #1712.

Canada Life first reported a position in CSTL in Q2 2020 and has held it in 24 quarters since. The position peaked at $378K in Q3 2024. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Canada Life held 3,244 shares of Castle Biosciences worth $80K as of Q1 2026.
  • Canada Life left its Castle Biosciences share count unchanged in Q1 2026.
  • Castle Biosciences made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1712 holding.
  • Canada Life first reported a position in Castle Biosciences in Q2 2020 and has held it in 24 quarters since.
  • Canada Life's Castle Biosciences position peaked at $378K in Q3 2024.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.